Puyana J C, Rode H N, Christou N V, Meakins J L, Gordon J
Department of Surgery, McGill University, Montreal, Quebec, Canada.
Surgery. 1990 Apr;107(4):442-8.
Groups of surgical patients, classified as reactive or anergic on the basis of delayed type hypersensitivity skin testing with five recall antigens, were immunized with keyhole-limpet hemocyanin (KLH) alone or KLH together with mediators derived from leukocytes of a KLH immune donor cultured with antigen. Patients with anergy injected with KLH alone did not generate an immune response as judged by a T cell proliferative reaction performed 14 days after immunization. In contrast, leukocytes of patients with anergy immunized with KLH together with the mediators reacted to KLH in vitro in similar numbers and with a magnitude comparable to that given by reactive, hospitalized patients without anergy immunized with KLH alone. These results confirm and extend our previous observations showing that anergy defined as a lack of cell-mediated immunity to recall antigens such as purified protein derivative extends to the generation of a systemic immune response to a neoantigen such as KLH and mediators that could restore a state of delayed hypersensitivity to purified protein derivative could also be instrumental in inducing cell-mediated immunity de novo when injected together with the antigen.
根据对五种回忆抗原进行迟发型超敏皮肤试验的结果,将外科手术患者分为反应性或无反应性两组。分别用钥孔戚血蓝蛋白(KLH)单独免疫,或用KLH与来自经抗原培养的KLH免疫供体的白细胞衍生介质共同免疫。单独注射KLH的无反应性患者在免疫14天后进行的T细胞增殖反应显示未产生免疫应答。相比之下,用KLH与介质共同免疫的无反应性患者的白细胞在体外对KLH的反应数量和强度,与单独用KLH免疫的无无反应性的反应性住院患者相当。这些结果证实并扩展了我们之前的观察结果,即定义为对诸如纯化蛋白衍生物等回忆抗原缺乏细胞介导免疫的无反应性,也会延伸至对诸如KLH等新抗原产生全身免疫应答,并且当与抗原一起注射时,能够恢复对纯化蛋白衍生物迟发型超敏状态的介质,也有助于重新诱导细胞介导免疫。